Cargando…
CK2 Activity Mediates the Aggressive Molecular Signature of Glioblastoma Multiforme by Inducing Nerve/Glial Antigen (NG)2 Expression
SIMPLE SUMMARY: Glioblastoma multiforme (GBM) is the most common and lethal primary malignant cancer of the central nervous system with a median patient survival of ~15 months. It has been reported that particularly nerve/glial antigen (NG)2-positive GBM is associated with an aggressive clinical phe...
Autores principales: | Schmitt, Beate M., Boewe, Anne S., Götz, Claudia, Philipp, Stephan E., Urbschat, Steffi, Oertel, Joachim, Menger, Michael D., Laschke, Matthias W., Ampofo, Emmanuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037969/ https://www.ncbi.nlm.nih.gov/pubmed/33918235 http://dx.doi.org/10.3390/cancers13071678 |
Ejemplares similares
-
Protein Kinase CK2 Regulates Nerve/Glial Antigen (NG)2-Mediated Angiogenic Activity of Human Pericytes
por: Schmitt, Beate M., et al.
Publicado: (2020) -
Inhibition of CK2 Reduces NG2 Expression in Juvenile Angiofibroma
por: Boewe, Anne S., et al.
Publicado: (2022) -
The regulatory mechanisms of NG2/CSPG4 expression
por: Ampofo, Emmanuel, et al.
Publicado: (2017) -
Protein Kinase CK2 Contributes to Glucose Homeostasis by Targeting Fructose-1,6-Bisphosphatase 1
por: Pack, Mandy, et al.
Publicado: (2022) -
Protein Kinase CK2—A Putative Target for the Therapy of Diabetes Mellitus?
por: Ampofo, Emmanuel, et al.
Publicado: (2019)